Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase
GSK shares advanced after the European Commission approved its asthma drug Exdensur and the company launched a £450 million share repurchase. New data also highlighted the effectiveness of its RSV vaccine.
Fortescue Gains as Wyloo Mine Enters Public Review, Results Loom
Fortescue shares advanced slightly as regulators began a public feedback period for its proposed Wyloo North iron ore mine. Investors are focused on the upcoming comment deadline and the company's half-year financial report.
Santos Prevails in Climate Lawsuit, Investors Eye Upcoming Earnings
Santos Ltd. shares edged lower following a court's dismissal of a climate-related lawsuit. Market attention now turns to the energy producer's upcoming annual financial results.
CoreWeave Confronts Legal Deadline Ahead of Q4 Earnings Report
CoreWeave navigates a securities lawsuit deadline while investors await quarterly results. Shares closed at $96.04 ahead of the Washington's Birthday market holiday.
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
Goldman Sachs Legal Chief's Exit Amid Epstein Ties Rattles Market
Goldman Sachs shares closed flat at $905.14 after the bank's top lawyer said she would retire in June, with Justice Department documents revealing she accepted gifts from Jeffrey Epstein. Markets head into a holiday-shortened week after major indexes posted their largest weekly declines since November.
Lilly's $1.5B Oral Obesity Pill Stockpile Signals Major Launch Ambitions
Eli Lilly has accumulated $1.5 billion in pre-launch inventory for its experimental oral obesity treatment orforglipron, with the FDA's target decision date set for April 10. The substantial stockpile highlights the company's push to overcome supply limitations that have hampered the GLP-1 market.
P&G Shares Dip Amid Italy Ad Probe, Insider Sale Ahead of Dividend
Procter & Gamble shares declined 0.7% to $160.07 amid an Italian advertising investigation and an insider stock sale, with the company's quarterly dividend scheduled for payment.